Metagenomix
About:
Metagenomix is an early-stage biotechnology company developing novel methods of screening microbes for pharmacologically-active compounds.
Top Investors: Connecticut Innovations, Elm Street Ventures
Description:
Metagenomix is an early-stage biotechnology company developing novel methods of screening microbes for pharmacologically active compounds. Among the indications under investigation are cancer, inflammation and infectious diseases including fungal infections and malaria. The technology also has applications in agriculture.
Total Funding Amount:
$700000
Headquarters Location:
Branford, Connecticut, United States
Founded Date:
2010-01-01
Founders:
Elias Theodorou, Michael Snyder
Number of Employees:
Last Funding Date:
2010-04-13
IPO Status:
Private
Industries:
© 2025 bioDAO.ai